Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Berg

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Circulation. Heart Failure|April 8, 2024
Early Serial Assessment of Aggregate Vasoactive Support and Mortality in Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network RegistrySiddharth M Patel, David D Berg, Erin A Bohula, et al.
Circulation|August 30, 2025
Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart FailureDavid D Berg, Siddharth M Patel, Paul M Haller, et al.
Circulation. Heart Failure|December 2, 2022
Clinician and Algorithmic Application of the 2019 and 2022 Society of Cardiovascular Angiography and Intervention Shock Stages in the Critical Care Cardiology Trials Network RegistrySiddharth M Patel, David D Berg, Erin A Bohula, et al.
Circulation|August 30, 2022
Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63BMarc P Bonaca, David A Morrow, Brian A Bergmark, et al.
European Heart Journal. Acute Cardiovascular Care|August 29, 2024
Epidemiology of cardiogenic shock using the Shock Academic Research Consortium (SHARC) consensus definitionsDavid D Berg, Erin A Bohula, Siddharth M Patel, et al.
Journal of the American College of Cardiology|October 2, 2024
Contemporary Training in American Critical Care Cardiology: Minnesota Critical Care Cardiology Education Summit: JACC Scientific Expert PanelAndrea M Elliott, Jason A Bartos, Christopher F Barnett, et al.
Circulation|August 29, 2022
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACTErin A Bohula, David D Berg, Mathew S Lopes, et al.
Journal of Cardiac Failure|February 27, 2025
Epidemiology and Prognostic Significance of Acute Noncardiac Organ Dysfunction Across Cardiogenic Shock SubtypesAnubodh S Varshney, Michael G Palazzolo, Christopher F Barnett, et al.
Journal of Cardiac Failure|February 28, 2025
Differences Between Ischemic and Nonischemic Cardiomyopathy in Heart Failure Related Cardiogenic ShockJason Feinman, Matthew I Tomey, Michael G Palazzolo, et al.
Journal of Cardiac Failure|October 9, 2021
De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network RegistryAnkeet S Bhatt, David D Berg, Erin A Bohula, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Circulation. Heart Failure|April 8, 2024
Early Serial Assessment of Aggregate Vasoactive Support and Mortality in Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network RegistrySiddharth M Patel, David D Berg, Erin A Bohula, et al.
Circulation|August 30, 2025
Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart FailureDavid D Berg, Siddharth M Patel, Paul M Haller, et al.
Circulation. Heart Failure|December 2, 2022
Clinician and Algorithmic Application of the 2019 and 2022 Society of Cardiovascular Angiography and Intervention Shock Stages in the Critical Care Cardiology Trials Network RegistrySiddharth M Patel, David D Berg, Erin A Bohula, et al.
Circulation|August 30, 2022
Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63BMarc P Bonaca, David A Morrow, Brian A Bergmark, et al.
European Heart Journal. Acute Cardiovascular Care|August 29, 2024
Epidemiology of cardiogenic shock using the Shock Academic Research Consortium (SHARC) consensus definitionsDavid D Berg, Erin A Bohula, Siddharth M Patel, et al.
Journal of the American College of Cardiology|October 2, 2024
Contemporary Training in American Critical Care Cardiology: Minnesota Critical Care Cardiology Education Summit: JACC Scientific Expert PanelAndrea M Elliott, Jason A Bartos, Christopher F Barnett, et al.
Circulation|August 29, 2022
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACTErin A Bohula, David D Berg, Mathew S Lopes, et al.
Journal of Cardiac Failure|February 27, 2025
Epidemiology and Prognostic Significance of Acute Noncardiac Organ Dysfunction Across Cardiogenic Shock SubtypesAnubodh S Varshney, Michael G Palazzolo, Christopher F Barnett, et al.
Journal of Cardiac Failure|February 28, 2025
Differences Between Ischemic and Nonischemic Cardiomyopathy in Heart Failure Related Cardiogenic ShockJason Feinman, Matthew I Tomey, Michael G Palazzolo, et al.
Journal of Cardiac Failure|October 9, 2021
De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network RegistryAnkeet S Bhatt, David D Berg, Erin A Bohula, et al.
Pageof 13